Apatinib plus icotinib in treating advanced non-small-cell lung cancer after icotinib treatment failure.

Jianping Xu,Xiaoyan Liu,Sheng Yang,Xiangru Zhang,Yuankai Shi

Apatinib plus icotinib in treating advanced non-small-cell lung cancer after icotinib treatment failure.

2017

Jianping Xu
Xiaoyan Liu
Sheng Yang
Xiangru Zhang
Yuankai Shi

e20528Background: Icotinib, a small-molecule EGFR TKI, has been approved as the first-line therapy for treating advanced non-small-cell lung cancer (NSCLC) in China. However, treatment failures fre...

Keywords:

Pathology
Icotinib
Apatinib
Lung cancer
Cancer research
Medicine
egfr tki
Oncology
Internal medicine
non small cell
treatment failure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations